학술논문

Longitudinal tracking of ALK -positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe21072-e21072, 1p
Subject
Language
ISSN
0732183X